Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2011-08-16
2011-08-16
Chen, Stacy B (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S204100, C536S023720
Reexamination Certificate
active
07998484
ABSTRACT:
The present invention provides the use of nucleic acid sequences and/or amino acid sequences in the preparation of a vaccine for the protection of fish against infectious salmon anemia virus. Specifically, such vaccines contain at least one nucleic acid sequence which is derived from ISAV or synthetically prepared analogues thereof, or substantially homologous sequences. These nucleic acid sequences are transcripted and translated into peptide sequences which are incorporated into a vaccination strategy to induce and immune response to the surface antigens of ISAV and therefore ISAV itself. Therefore both the use of a vaccine against ISAV, and the incorporation of peptide sequences is herein described.
REFERENCES:
patent: 6471964 (2002-10-01), Biering et al.
patent: 1180041 (2006-03-01), None
patent: 1637614 (2006-03-01), None
patent: 1200132 (2007-07-01), None
patent: WO/00/72878 (2000-12-01), None
patent: WO/ 01/ 49712 (2001-01-01), None
patent: WO/01/66569 (2001-09-01), None
patent: WO/02/26784 (2002-04-01), None
Rocco C. Cipriano, Infectious Salmon Anemia Virus, US Geological Survey, Fish Disease Leaflet #85, 2003, pp. 1-11, available from www.lsc.usgs.gov/fhb/leaflets/FHB85.pdf.
Anderson, D.P., “Adjuvants and Immunostimulats for Enhancing Vaccine Potency in Fish,” Dev. Biol. Stand. 90:257-265 (1997).
Blake, S. et al., “Genomic Relationships of the North American Isolate of Infectious Salmon Anemia Virus (ISAV) to the Norwegian Strain of ISAV,” Dis. Aquat. Org. 35(2):139-144, XP000984527 (1999).
Davis, H. et al., “DNA Vaccines for Viral Diseases,” Microbes and Infection, 7-21 (1999).
Falk, K. et al., “Demonstration of a Protective Immune Response in Infectious Salmon Anaemia (ISA)-infected Atlantic SalmonSalmo salar,” Dis. of Aquat. Org., 21:1-5 (1995).
Falk, K., et al., “Characterization and Applications of a Monoclonal Antibody Against Infectious Salmon Anaemia Virus,” Dis. of Aquat. Org., 34:77-85 (1998).
Falk, K., et al., “Characterization of Infectious Salmon Anemia Virus an Orthomyzo-Like Virus Isolated from Atlantic Salmon (Salmo salarL.),” Journal of virology, 71(12):9016-9023 (1997).
Griffiths, et al., “Charactrization of ISAV Proteins from Cell Culture,” Dis. of Aquat. Org., 45:19-24 (2001).
Horne, M.T., “Technical Aspects of the Administration of Vaccines,” Dev. Biol. Stand., 90:79-89 (1997).
Kanellos, T., et al., “The Safety and Longevity of DNA Vaccines for Fish,” Blackwell Science Ltd Immunology, 96:306-313 (1999).
Kibenge, et al., “Antigenic Variation Among Isolates of Infectious Salmon Anaemia Virus Correlates with Genetic Variation of the Viral Haemagglutinin Gene,” Journal of General Virology, 82:2869-2879 (2001).
Krossy, B., et al., “Cloning and Identification of the Infectious Salmon Anaemia Virus Haemagglutinin,” Journal of General Virology, 82:1757-1765 (2001).
Krossy, B., et al., “The Putative Polymerase Sequence of Infectious Salmon Anemia Virus Suggests a New Genus within the Orthomyxovirdae,” Journal of Virology, 73(3):2136-2142, XP000986368 (1999).
Leong, J.C., et al., “Fish Vaccine Antigens Produced or Delivered by Recombinant DNA Technologies,” Dev. Biol. Stand. 90:267-277 (1997).
Lorenzen, N., et al., “Immunization with viral antigens: Viral Haemorrhagic Septicaemia,” Dev. Biol. Stand., 90:201-209 (1997).
Lovely, J.E., et al., “First Identification of Infectious Salmon Virus Anaemia Virus in North America with Haemorrhagic Kidney Syndrome,” Dis. of Aquat. Org., 35(2): 145-148, XP000984528 (1999).
Mjaaland, et al., “Genomic Characterization of the Virus Causing Infectious Salmon Anemia in Atlantic Salmon (Salmo salarL.): an Orthomyxo-Like Virus in Teleost,” Journal of Virology, 71(10):7681-7686 (1997).
Rimstad, et al., “Characterization of the Infectious Salmon Anemia Virus Genomic Segment that Enclosed the Putative Haemagglutinin,” Journal of Virology, 75(11):5352-5356 (2001).
Ritchie, et al., Virus Genes, 22(3):289-297 (2001).
Winton, J.R., “Immunization with Viral Antigens: Infectious Haematopoietic Necrosis,” Dev. Biol. Stand., 90:211-220 (1997).
Griffiths Steven
Heppell Joel
Ritchie Rachael Jane
Chen Stacy B
Novartis AG
Ottawa Health Research Institute
LandOfFree
Nucleic acid and amino acid sequences of infectious salmon... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid and amino acid sequences of infectious salmon..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid and amino acid sequences of infectious salmon... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2663321